Gc. Brown et al., Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization, OPHTHALMOL, 107(7), 2000, pp. 1374-1380
Objective: To perform a patient preference-based, incremental cost-effectiv
eness analysis for laser treatment of subfoveal choroidal neovascularizatio
n.
Design: Computer-based econometric modeling.
Methods: The cost effectiveness of laser photocoagulation therapy was compa
red with the natural course of subfoveal choroidal neovascularization. The
model applied long-term visual data from previous clinical trials, utility
analysis (which reflects patient perceptions of quality of life associated
with a health state), decision analysis with Markov modeling, and the econo
mic principles of present value analysis with discounting to account for th
e time value of money.
Database: Data from patients eligible for treatment of subfoveal choroidal
neovascularization obtained by researchers in the Macular Photocoagulation
Study were used for the analysis. Interventions Modeled laser therapy for s
ubfoveal choroidal neovasacularization in patients with age-related macular
degeneration.
Main Outcome Measure: Cost per quality-adjusted life-year ($/QALY gained) a
ssociated with laser therapy,
Results: Laser photocoagulation therapy for subfoveal choroidal neovascular
ization, as compared with no treatment, resulted in a mean gain of 0.257 QA
LYs per treated patient. Using a yearly discount rate of 3% to account for
the time value of money and inflation, the resultant $/QALY gained was $562
9. Sensitivity analysis used in the cost-effectiveness analysis resulted in
a $/QALY gained of $4974 with no gained discount rate and $11,633 with a y
early discount rate of 10%.
Conclusions: The incremental expense of laser therapy for the treatment of
subfoveal choroidal neovascularization appears to be highly cost effective.
The result, which takes into account patient preference-based utility data
, compares quite favorably with other interventional therapies across diffe
rent medical specialties. (C) 2000 by the American Academy of Ophthalmology
.